Boundary Issues in Clinical Practice
FACULTY
Thomas G. Gutheil, MD
Professor of Psychiatry
Beth Israel Deaconess Medical Center
Massachusetts Mental Health Center
Harvard Medical School
Boston, Massachusetts
For full faculty bios, please call 609-371-1137.
TO DOWNLOAD SLIDES CLICK HERE.
INTENDED LEARNERS
This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with mental health disorders.
LEARNING OBJECTIVES
After completing this activity, participants should be able to:
- Distinguish between boundary crossings and boundary violations
- Review best practices in avoiding boundary problems
- Apply proven strategies to avoid common problem pitfalls in dealing with difficult patients
ACTIVITY OVERVIEW
To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: 12/1/2018
Expiration Date: 12/31/2019
Estimated time to complete: 1.25 hours
For questions regarding this educational activity, please call 609-371-1137.
ACCREDITATION INFORMATION
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME
NACCME designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PHYSICIAN ASSISTANTS
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 credit(s). PAs should only claim credit commensurate with the extent of their participation in the activity.
CNE
This continuing nursing education activity awards 1.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.25 contact hours.
CE INFORMATION: APA
North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.
Instructional Level: Advanced
PLANNING COMMITTEE
The planning committee comprises Thomas G. Gutheil, MD; James Cannon, PhD, MS, PA-C, CAQ-Psy, DFAAPA; Julie Carbray, PhD, FPMHNP, PMHCNS; Jon W. Draud, MD, MS; Rakesh Jain, MD, MPH; Saundra Jain, MA, PsyD, LPC; Catherine Judd, MS, PA-C, CAQ-Psy, DFAAPA; Vladimir Maletic, MD, MS; Dougles Noordsy, MD; Andrew Penn, RN, MS, NP, CNS, APRN-BC; Charles L. Raison, MD; William C. Torrey, MD; and Meaghan Benci, Raquel Gaerlan, Jennifer Ilcyn, Randy Robbin, Horacio Rodriguez, Kelly Sweeney, and Susan Yarbrough.
Independent Clinical Reviewers:
Douglas L. Noordsy, MD
Clinical Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine; Director of Sports Psychiatry, Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, California
William C. Torrey, MD
Professor and Vice Chair for Clinical Services, Dartmouth’s Geisel School of Medicine, Dartmouth-Hitchcock, Lebanon, New Hampshire
Nurse Planner:
Andrew Penn, RN, MS, NP, CNS, APRN-BC
Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA
FINANCIAL DISCLOSURE AND CONFLICTS OF INTEREST
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty reported the following:
Dr. Gutheil has authored or co-authored circa 300 publications, some of which generate income.
Dr. Carbray: Consultant—Neurocrine.
Dr. Rakesh Jain: Advisory Board—Addrenex, Alkermes, Avanir, Forum, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant—Addrenex, Allergan, Avanir, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant (spouse)—Lilly, Otsuka, Pamlab, Sunovion; Grant/Research Support—AstraZeneca, Allergan, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers Bureau—Addrenex, Alkermes, Allergan, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Rhodes, Shionogi, Shire, Sunovion, Takeda, Tris Pharmaceuticals.
Dr. Saundra Jain: Advisory Board (spouse)—Addrenex, Alkermes, Avanir, Forum, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Consultant—Lilly, Otsuka, Pamlab, Sunovion; Consultant (spouse)—Addrenex, Allergan, Avanir, Janssen, Lilly, Lundbeck, Merck, Neos Therapeutics, Neurocrine Biosciences, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Supernus, Takeda, Teva; Grant/Research Support (spouse)—AstraZeneca, Allergan, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda; Speakers Bureau (spouse)—Addrenex, Alkermes, Allergan, Lilly, Lundbeck, Merck, Neos Therapeutics, Otsuka, Pamlab, Pfizer, Rhodes, Shionogi, Shire, Sunovion, Takeda, Tris Pharmaceuticals.
Dr. Maletic: Consultant—Alkermes, Inc., Allergan, Lundbeck A/S, Otsuka America Pharmaceutical, Inc., Shire, Sunovion Pharmaceuticals Inc., Supernus Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd.; Speakers Bureau—Alkermes, Inc., Allergan, H. Lundbeck A/S, Otsuka America Pharmaceutical, Inc., Sunovion Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, Teva; Speakers Honoraria (spouse)—Otsuka.
Dr. Raison: Consultant—Alkermes, Emory Healthcare, Novartis, Usona Institute.
Dr. Draud, Ms. Judd, Dr. Noordsy, Mr. Penn, and, Dr. Torrey have disclosed no relevant financial relationships with any commercial interests.
Ms. Benci, Ms. Gaerlan, Ms. Ilcyn, Mr. Robbin, Mr. Rodriguez, Ms. Sweeney and Ms. Yarbrough have disclosed no relevant financial relationships with any commercial interests.
UNAPPROVED AND INVESTIGATIONAL USES OF DRUGS AND DEVICES
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) of the United States or European Medicines Agency (EMA). Participants are encouraged to consult the EMA-approved or FDA-approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed in this document are the opinions of the presenters and do not necessarily reflect the opinions of Imedex, LLC and/or NACCME, LLC.
HARDWARE/SOFTWARE REQUIREMENTS
The evaluation is accessible after the activity via a PC (Windows 7 or newer) or Mac (Mac OS 10.6 or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
PRIVACY POLICY
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2018 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.